Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«EPO

Below is an extended EPO publications listing. Click here to return to the gene page.

Gene Information from Publications

Publication Link Summary of findings
18219110 study shows breast epithelial cells are a source of Epo in breast microenvironment, suggesting presence of a paracrine/autocrine Epo function in Nipple Aspirate Fluids, triggering intracellular signaling cascade with subsequent breast cancer initiation
18160550 Erythropoietin levels in cord blood were not different between preterm infants with and without periventricular leukomalacia.
17888545 Observational study of gene-disease association. (HuGE Navigator)
18093155 Administration of rhEPO protects neurons by enhancing Bcl-2 expression, thereby inhibiting traumatic brain injury-induced neuronal apoptosis.
18201556 In vitro biological activity of egg white-hEpo was comparable to that produced by recombinant CHO cells.
17984928 Erythropoietin levels in the familial cases of restless leg syndrome were significantly lower than in the reference population.
18091448 aqueous humor EPO level is increased in eyes with primary open-angle glaucoma.
17952604 results suggest that PI3K/Akt and GSK-3beta pathway are involved in the neuroprotective effect of EPO
17577097 Erythopoietin confers immediate and sustained protection of the heart against injury from ischemia/reperfusion by a mechanism involving activation of protein kinases and ATP-dependent potassium channels.
17540710 Data show that human scalp hair follicles express erythropoietin (EPO), up-regulate EPO transcription under hypoxic conditions, and express transcripts for EPO receptors and the EPO-stimulatory transcriptional cofactor hypoxia-inducible factor-1alpha.
17893874 erythropoietin receptor and erythropoietin have roles in the autocrine/paracrine mechanism of growth enhancement in human ovarian cancer cells
17893875 Epo has a role in reducing expression of apoptosis-related proteins Bcl-2 and Bcl-10 in ovarian cancer cells
17467346 Review discusses studies on EPO circadian, monthly and even annual variations; studies in connection with short-, medium- and long-term exercise at sea-level and studies performed at moderate and high altitude [review].
18074690 Recovery of neurological function in a model of peripheral nerve injury is more rapid with weekly administration of darbepoetin alfa than with daily recombinant human erythropoietin treatment.
17713555 hTERT appears to be efficiently regulated by EPO and TGFbeta in an opposite way in erythropoietic cells, arguing for a role of telomerase in red blood cell production
17873970 EPO protects the intestine against ischemia/reperfusion injury in rats.
17481772 Blockade of Epo inhibits retinal neovascularization in vivo, and inhibits endothelial cell proliferation response in diabetic reginopathy.
17145806 Cervical cancers with higher Epo expression showed a significantly reduced overall survival and correlated significantly with apoptosis.
17652365 The impact of Epo overexpression in mice and the resulting excessive erythrocytosis in the neural control of normoxic and hypoxic ventilation is reported.
17615151 EPO contributes to regulation of hypothalamo-pituitary-adrenal (HPA) axis activation; in pathological conditions such as brain ischemia, this growth factor may control HPA axis function, preventing possible detrimental effects of HPA overactivation.
16838166 bicycle taxi drivers with subclinical lead toxicity have decreased serum EPO
17647284 Epo and EpoR were expressed neuroblastomas but did not modify tumor cell proliferation.
17645631 Erythropoietin has a significant angiogenic effect in rat kidney with cyclosporine A-induced nephrotoxicity.
17395782 Adaptive mechanisms to hematocrit levels of erythropoietin-overexpressing transgenic mice show increased plasma nitric oxide levels and erythrocyte flexibility.
17636183 Review. Epo exhibits a "tissue-protective" effect on nonhematopoietic tissues, possibly mediated through a novel heteroreceptor, blocking apoptosis by a variety of insults. However, Epo may have a potential direct growth-promoting action on cancer cells.
12476588 may play an important role in signal transduction via EpoR on erythroid progenitor in CRF patients.
15671524 erythropoietin and EPOR are co-expressed in tumor cells, suggesting that erythropoietin may potentially function as an autocrine or paracrine factor in head and neck cancer
17081058 Lysine-containing peptides comprising glycosylation sites derived from recombinant human erythropoietin were derivatized with 2-methoxy-4,5-dihydro-1H-imidazole and its deuterated analogues.
11854521 used a transient global spinal ischemia model in rabbits to test whether exogenous EPO can cross the blood-spinal cord barrier and protect these motor neurons.
14724429 Overexpression of EPO protects islets from destruction and does not compromise islet function. Genetic engineering with EPO may improve islet survival and engraftment in transplant setting, but regulation of gene expression will be important prerequisite.
11861258 Carbohydrate content and structure of EPO are important determinants in their half-life in the circulation.
12801298 hemoglobin levels are related to the rise in serum EPO that occurs during pregnancy
11869305 renal failure patients mounted an EPO response to hypoxia but at lower EPO levels
16332412 Therefore, rhEPO could be an effective drug for the prevention of hearing loss via a hair cell protective mechanism.
15389732 erythropoietin has a protective role against cancer and brain injury [review]
16467207 Binding of the transcriptionally competent Wt1(-KTS) isoform to the minimal EPO promoter was demonstrated; this promoter was activated up to 20-fold by transient cotransfection of Wt1(-KTS) in different cell lines.
16627979 Coexpression of erythropoietin and its receptor plays a important role in tumorigenesis of sporadic clear cell renal cell carcinoma.
16909043 EPO, at pharmacological concentrations, can activate three major signalling cascades, viz. the Jak2/STAT5, Ras/ERK and PI3K/Akt pathways in non-small cell lung carcinoma (NSCLC) cell lines
12171772 Increased levels of circulating thrombopoietin were found in patients with clonal thrombocytosis versus patients with reactive thrombocytosis, indicating a potential differential diagnosis tool.
15339684 The performance-enhancing effect of recombinant erythropoietin treatment is greater than the duration and diagnosis of hematologic changes associated with recombinant erythropoietin misuse.
15705187 in vivo EPO does not affect the functionality and/or production of components of the VEGF/Flt-1 system in diabetics with normal or reduced renal function.
17597020 Statistically analyzed distributions of the proteins reflected functional dependences among STAT3, HIF-1alpha, EPO and EPOR in cellular signal conduction.
16936148 Erythropoietin is expressed in the human retina, and it is upregulated in diabetic patients even without retinopathy.
14704034 EPO stimulation significantly increased the level of Akt phosphorylation, the downstream target of PI3-kinase.
14990112 EPO levels increased incompensatively in anemia of chronic disease (ACD) children, which may be a cause of ACD.
12207089 REVIEW: pathways by which transcription of erythropoietin is regulated by availability of molecular oxygen
15467711 Epression of erythropoietin in prostate cancer cell lines suggesting that these cells may serve as useful experimental models for further studies of erythropoietin function for growth regulation in prostate cancer.
16278379 Erythropoietin and erythropoietin receptor are expressed in head and neck squamous cell carcinoma
12239177 hypoxia-inducible gene expression in human neuroblastoma cells
12482504 a key role for NF-kappaB in EPO gene regulation in response to hypoxia
12525458 Epo and Epo-R localized within glandular epithelial cells in both peritoneal endometriosis and eutopic endometrium. Role in pathophysiology of endometriosis.
12381912 All regions of kidney express erythropoietin receptors. Review.
12091337 Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB.
11920206 Two to three weeks after initiation of hydroxyurea treatment, the sEpo values started to increase and reached levels three to 31 times higher than the baseline two to three weeks later.
15210945 EPO+IGF-I exert cooperative actions that afford acute neuroprotection via activation of the PI3-K-Akt pathway
12829027 protein CBP/p300 was shown to be essential for EPO- and SCF-mediated STAT5 transactivation
15019812 Erythropoietin protein was constitutively present in seminal plasma. The seminal EPO originated from the prostate and seminal vesicle. No association between EPO levels in seminal plasma and sperm parameters was found.
14583613 GATA-4 is critical for transcription of the Epo gene in hepatocytes and may contribute to the switch in the site of Epo gene expression from the fetal liver to the adult kidney
15183662 Initial studies of recombinant erythropoietin as therapy for infants with neurologic injury are encouraging. Review.
15257091 erythropoietin has a role in healing of ischemic skin wounds
15988318 Multiple logistic regression revealed a significant association between the appearance of nucleated RBCs in the blood and erythropoietin, IL-3, IL-6, and age.
16684536 NF-kappaB is probably the primary transcription factor by which cAMP counteracts the inhibition of Epo gene expression by IL-1.
17045782 A "classical" homodimeric erythropoietin receptor is essental for the antiapoptotic effects of Epo on differentiated neuroblastoma SH-SY5Y cells.
17372034 EPO prevents aberrant remodeling of the injured carotid artery. The protective effects of EPO are critically dependent on activation of eNOS.
17389738 rhEPO treatment inhibits the progression of renal fibrosis in obstructed kidney and attenuates the TGF-beta1-induced epithelial-to-mesenchymal transition.
11994541 While both Epo and Epo-R were detected in all samples of isolated epithelial cells analysed throughout the menstrual cycle, neither one was detected in isolated stromal cells. Epo and Epo-R protein expression in glandular epithelial cells was increased
12759237 Results suggest that increased expression of erythropoietin may play a significant role in cervical carcinogenesis and tumor progression.
12937140 Novel function for EPO by providing in vivo evidence for a physiological role during fibrin-induced wound healing.
12975460 These findings suggest that recombinant human erythropoietin (EPO) attenuates ischemia-induced inflammation by reducing neuronal death rather than by direct effects upon EPO-receptor-expressing inflammatory cells.
15205261 erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production in vascular endothelial cells
15363820 Increased erythropoietin may be a potential reversible mechanism to explain the association between obstructive sleep apnea and cardiovascular disease.
15709164 erythropoietin was expressed in one half of samples by immunohistochemistry and in 100% of samples by mRNA detection in non-small cell lung carcinomas.
15709172 Results showed that VHL disease-associated renal clear cell carcinomas and renal cysts coexpress erythropoietin and erythropoietin receptor.
15718359 EPO may have a role in oxygenation during gestation and placental sufficiency, as seen in this study of monozygotic and dizygotic twins' cord blood analysis
15795697 Hemoglobin and serum EPO levels were significantly higher in the chronic obstructive lung disease group than in pulmonaary fibrosis patients and controls.
15777837 the erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptor
14747752 Results show that recombinant human erythropoietin reduces brain injury, especially apoptotic cell death, after neonatal hypoxia-ischemia.
15053948 Review summarizes current knowledge of the nonerythropoietic roles of Epo, its neurotrophic and neuroprotective properties, the mechanisms by which Epo produces neuroprotection and the signal transduction systems regulated by Epo in the nervous system.
12734640 Inhibition of erythropoietin(Epo) gene expression by cadmium depends on suppression of hypoxia-inducible factor 1(HIF-1) binding activity.
15590452 Further investigations are needed to understand the mechanism of the hepatoprotective effect of erythropoietin and the clinical importance of ischemic liver injury in the fetus.
15627795 Angiotensin II does not alter EPO production in HepG2 cell culture under normoxic or hypoxic conditions.
15769989 Coexpression of Erythropoietin and Erythropoietin receptor was found in all five Hippel Lindau disease-associated pheochromocytomas.
15993382 In conclusion, erythropoietin may attenuate high glucose-induced endothelial cell apoptosis via PI-3 kinase pathway.
16699298 findings show that three thyroid cancer cell lines expressed Epo and EpoR mRNA and that the hypoxia-mimetic cobalt induced Epo expression
11906321 Serum erythropoietin levels (s-[epo]), haemoglobin concentration ([Hb]), haematocrit (hct), and ferritin concentration ([fer]) were measured in seven healthy male volunteers (20-23 years) exposed continuously to hypoxia (PO(2) 14 kPa) for 10 days
11906322 Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans.
12187026 data suggest that although chronic lymphocytic leukemia (CLL) anemia is not characterized by inadequate Epo production, in some CLL patients this factor may be correlated; in these cases, levels of TNF-alpha were higher than in other anemic cases
16123502 Elevated in vitreous fluid of patients with proliferative diabetic retinopathy.
16883594 The effect of 2-oxoglutarate on the production of erythropoietin and vascular endothelial growth factor (VEGF), was examined.
14755373 Erythropoietin deficiency may be one of the endocrine abnormalities associated with autoimmune polyglandular syndrome type I.
15502930 Prenatal high amniotic fluid erythropoietin levels can identify type 1 diabetic pregnancies at increased risk of severe perinatal complications.
12419827 erythropoietin signalling contributes to the growth and/or survival of both transformed cells and capillary endothelial cells in female reproductive system tumours.
14671634 after rHuEpo stimulation in the chick embryo chorioallantoic membrane assay, the generation of new blood vessels occurred more frequently following an intussusceptive microvascular growth mechanism
12362243 triggers a signaling pathway (MAPK p42/44) in vascular endothelial cells and increases the thrombogenicity of their extracellular matrices
15240563 the complete EPO enhancer displayed dependency on HIF-2alpha regulation, indicating that additional cis-acting elements confer HIF-2alpha specificity within this region
15112358 Results show no significant difference in erythropoietin values between non-anemic patients with liver disease and controls.
15160341 Increased erythropoietin expression is associated with endometrial carcinoma
15347669 Brahma and Brahma/SWI2-related gene 1 have roles in hypoxic induction of the erythropoietin gene
15856028 results define a novel role for EPO in mediating tumor cell invasion; increased levels of EPO/EPOR in lymph node metastases as compared to primary tumors from HNSCC patients further support the role of EPO/EPOR in HNSCC disease progression and metastasis
16645141 Epo treatment inhibits neointimal hyperplasia after arterial injury in NO-dependent manner by acting on injured vessels and mobilizing endothelial progenitor cells to neo-endothelium.
11865075 Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
11919332 Data suggest that erythropoietin may be an endogenous stimulant of blood vessel growth during neonatal gastrointestinal development.
14584755 Only a minority of papillary thyroid carcinomas (PTC) expressed EPO, and there were no significant differences between the PTC that did or did not express EPO.
15142852 EPO is important for development of the brain and is neuroprotective, whereas it stimulates angiogenesis in the reproductive tract and possibly in other organs--REVIEW
12463751 Direct comparison of nonglycosylated vs. glycosylated EPO demonstrates how both carbohydrate core structure and sialic acid can dampen electrostatic contributions to receptor association rate constant with little effect on dissociation rate.
15743794 autocrine and paracrine functions of Epo might play a role in malignant transformation of melanocytes and in the survival of melanoma cells in hypoxia
15967106 Erythropoietin signaling has a role in promoting invasiveness of human head and neck squamous cell carcinoma
16229477 under a variety of conditions rEPO undergoes thermal or urea-induced denaturation that may be considered as a reversible two-state process characterized by unusually high (thermal) or moderate (urea-induced) extent of the residual structure
16286456 Epo is degraded faster than NESP at the cellular level
17360900 Epo increases hippocampus response during picture retrieval compared with placebo independent of changes in hematocrit.
15728783 Recombinant human erythropoietin treatment of endothelial cells causes a significant increase in asymmetric dimethylarginine (ADMA) levels in the cell culture medium.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.